S. 4987 · 119th Congress (2025–2027)
Pharmaceutical Investment Oversight and Accountability Act
A bill to require the Federal Trade Commission to submit a report on foreign investment in the pharmaceutical industry of the United States, and for other purposes.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is S. 4987’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
- Sponsor
- Sen. Elizabeth Warren (D-MA)
- Cosponsors
2 cosponsors
2 original · 0 later
- Sen. Kirsten E. Gillibrand (D-NY)· Original · Jul 15, 2026
- Sen. Rick Scott (R-FL)· Original · Jul 15, 2026
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Sources
- Congress.gov action
- Senate
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
Pharmaceutical Investment Oversight and Accountability Act
Display title, Short title · Introduced in Senate
A bill to require the Federal Trade Commission to submit a report on foreign investment in the pharmaceutical industry of the United States, and for other purposes.
Official title · Introduced in Senate